更新時間：2025-12-17
高憲立Kao, Hsien Li
- 計畫主持人
- 執行臨床試驗年資 23 年 9 個月
-
juching2024@gmail.com
發表文獻
53筆
21
Ko TY, Kao HL, Chen YC, Lin LC, Liu YJ, Yeh CF, Huang CC, Chen YH, Chen YS, Lin MS. Temporal Change in Paravalvular Leakage after Transcatheter Aortic Valve Replacement with a Self-Expanding Valve: Impact of Aortic Valve Calcification. Acta Cardiol Sin. 2020 Mar;36(2):140-147. doi: 10.6515/ACS.202003_36(2).20190709B. PMID: 32201465; PMCID: PMC7062810.
22
Ko TY, Kao HL, Chen YC, Yeh CF, Huang CC, Chen YH, Chan CY, Lin LC, Wang MJ, Chen YS, Lin MS. Results of streamlining TAVR procedure towards a minimalist approach: a single center experience in Taiwan. Sci Rep. 2023 Nov 6;13(1):19134. doi: 10.1038/s41598-023-46475-4.PMID: 37932391
23
Ko TY, Kao HL, Liu YJ, Yeh CF, Huang CC, Chen YH, Hung CS, Chan CY, Lin LC, Chen YS, Lin MS. Intentional combination of ProGlide and Angio-Seal for femoral access haemostasis in transcatheter aortic valve replacement. Int J Cardiol. 2019 Oct 15;293:76-79. doi: 10.1016/j.ijcard.2019.05.055. Epub 2019 May 23. PMID: 31155328.
24
Ko TY, Kao HL, Yeh CF, Lin JH, Huang CC, Chen YH, Chao CC, Li HY, Chan CY, Lin LC, Chen YS, Wang MJ, Lin MS. Serial nerucognitive changes following transcatheter aortic valve replacement: comparison between low and intermediate-high risk groups. Aging (Albany NY). 2022 Aug 5;14(15):6111-6127. doi: 10.18632/aging.204202. Epub 2022 Aug 5.PMID: 35939340
25
Ko TY, Kao HL, Yeh CF, Lin JH, Huang CC, Chen YH, Chao CC, Li HY, Chan CY, Lin LC, Chen YS, Wang MJ, Lin MS. Serial neurocognitive changes following transcatheter aortic valve replacement: comparison between low and intermediate-high risk groups. Aging (Albany NY). 2022 Aug 5;14(15):6111-6127. doi: 10.18632/aging.204202. Epub 2022 Aug 5. PMID: 35939340; PMCID: PMC9417238.
26
Ko TY, Lin JH, Huang KC, Wei LY, Ho YL, Kao HL, Yu HY. Effects of short-term oral anticoagulation following surgical bioprosthesis aortic valve replacement. J Formos Med Assoc. 2023 Jan;122(1):58-64. doi: 10.1016/j.jfma.2022.08.006. Epub 2022 Aug 31.PMID: 36057527
27
Ko TY, Lin TT, Hsu JC, Yang YY, Chuang SL, Lin LY, Kao HL, Ho YL. Incidence, risk factors and predictors of cardiovascular mortality for aortic stenosis among patients with diabetes mellitus. Diabetes Res Clin Pract. 2022 Sep;191:110050. doi: 10.1016/j.diabres.2022.110050. Epub 2022 Aug 27.PMID: 36030901
28
Lee CH, Wang CY, Kao HL, Wu WK, Kuo CH. Differentiation of Alkyl- and Plasmenyl-phosphatidylcholine by Endogenous Sphingomyelin RT-XLOGP3 Regression for Coronary Artery Disease Plasma Lipidomics Analysis. Anal Chem. 2023 Nov 21;95(46):16902-16910. doi: 10.1021/acs.analchem.3c02693. Epub 2023 Nov 6.PMID: 37931321
29
Lee CK, Wang TD, Lee YH, Fahy M, Lee CH, Sung SH, Kao HL, Wu YW, Lin TH. Efficacy and Safety of Renal Denervation for Patients with Uncontrolled Hypertension in Taiwan: 3-Year Results From the Global SYMPLICITY Registry-Taiwan (GSR-Taiwan). Acta Cardiol Sin. 2019 Nov;35(6):618-626. doi: 10.6515/ACS.201911_35(6).20190826A. PMID: 31879514; PMCID: PMC6859098.
30
Lee JH, Ahn JM, Kang DY, Kim KW, Koo HJ, Yang DH, Jung SC, Kim B, Wong YTA, Lam CCS, Yin WH, Wei J, Lee YT, Kao HL, Lin MS, Ko TY, Kim WJ, Kang SH, Yun SC, Ko E, Park H, Lee SA, Kim DH, Park SJ, Park DW; ADAPT-TAVR Investigators. Effect of Edoxaban Versus Antiplatelet Therapy on Leaflet Thrombosis and Cerebral Thromboembolism After TAVI According to Major Clinical and Anatomic Factors in Prespecified Subgroup Analysis from the ADAPT-TAVR Trial. Am J Cardiol. 2023 Sep 15;203:352-361. doi: 10.1016/j.amjcard.2023.06.018. Epub 2023 Jul 28.PMID: 37517131
